Added to YB: 2025-11-21
Pitch date: 2025-10-16
DXCM [bullish]
DexCom, Inc.
+9.07%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$66.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
Aristotle Atlantic Core Equity Strategy New Position: DexCom, Inc.
DXCM (new position): CGM leader w/ clean balance sheet & robust FCF generation. Organic revenue growth in FY25, multi-year earnings expansion ahead. Stelo launch targeting non-diabetics, G7 transition w/ longer sensor life. Expanding into large non-intensive type 2 diabetes market w/ positive reimbursement trends.
Read full article (1 min)